Explore 3 Stock Ideas & Industry Insights Download Free Report

Natural Alternatives International

Company price
0.9666 USD 0.02 ( 1.69%)
Last update at 2026-11-13T21:00:00Z
VOLUME
21279
Market Cap
12.36M

Momentum Score

…

Natural Alternatives International, Inc. engages in formulating, manufacturing, and marketing nutritional supplements in the United States and internationally. It operates through two segments: Private-Label Contract Manufacturing, and Patent and Trademark Licensing. The company offers private-label contract manufacturing services to companies that market and distribute vitamins, minerals, herbal, and other nutritional supplements, as well as other health care products. It also provides strategic partnering services, such as customized product formulation, clinical study design and support, manufacturing, marketing support, international regulatory and label law compliance, international product registration, packaging in multiple formats and labeling design, scientific research, proprietary ingredients, customer-specific nutritional product formulation, product testing and evaluation, marketing management, packaging and delivery system design, regulatory review, and international product registration assistance. In addition, the company sells beta-alanine ingredient under the CarnoSyn, TriBsynm, and SR CarnoSyn names. The company manufactures products in various forms, including capsules, tablets, chewable wafers, and powders. Its private-label contract manufacturing customers include companies that market nutritional supplements through direct sales marketing channels, direct to consumer e-commerce channels, and retail stores. Natural Alternatives International, Inc. was founded in 1980 and is headquartered in Carlsbad, California.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.96
Low
1.06
High
52 Week Price Range
1.90
Low
4.96
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Natural Alternatives International, Inc. manufactures and supplies dietary supplements and nutritional ingredients and provides contract manufacturing along with related R&D and packaging services for consumer health brands. Long-term growth drivers include secular demand for health and wellness products, continued outsourcing of production by brand owners, and potential international expansion, which may benefit revenue diversification and operational scale; investors may find the company attractive for its manufacturing capabilities and service-oriented model.

Key risks include regulatory and quality-compliance exposure in the dietary-supplement sector, competitive pressures and pricing, and supply-chain and raw-material cost volatility that could affect production and profitability.

Risk Score
Medium

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
0.95
Dividend Yield
-
Revenue TTM
141.87M
Revenue Per Share
23.60
Gross Profit TTM
10.81M
Debt / Equity
0.86
ROE
-20.57%
Net Debt
46.70M
ROCE
-5.90%
Diluted EPS TTM
-2.40

Insight Announcement

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Income before tax -10.74M -9.46M 3.56M 13.66M 12.12M
Net income -13.57M -7.22M 2.52M 10.71M 10.77M
Selling general administrative 16.15M 15.10M 14.87M 16.95M 16.90M
Selling and marketing expenses 0.40M 0.30M - - -
Gross profit 9.29M 6.87M 18.16M 30.51M 30.44M
Reconciled depreciation 4.56M 4.65M 4.25M 4.17M 4.34M
Ebit -7.26M -9.10M 4.66M 13.68M 9.33M
Ebitda -2.70M -4.46M 8.91M 17.79M 13.67M
Depreciation and amortization 4.56M 4.65M 4.25M 4.11M 4.34M
Operating income -8.66M -8.53M 4.71M 13.68M 9.33M
Other operating expenses 138.52M 122.33M 149.30M 157.29M 164.85M
Interest expense 0.92M 0.36M 0.45M 0.08M 0.12M
Tax provision 2.83M -2.25M 1.03M 2.95M 1.36M
Interest income 0.17M 0.18M 0.03M 0.00M 0.00M
Net interest income -0.75M -0.18M -0.42M -0.08M -0.12M
Income tax expense 2.83M -2.25M 1.03M 2.95M 1.36M
Total revenue 129.86M 113.80M 154.01M 170.97M 178.52M
Total operating expenses 17.95M 15.40M 13.45M 16.83M 16.77M
Cost of revenue 120.57M 106.93M 135.86M 140.46M 148.08M
Total other income expense net -2.08M -0.93M -0.74M -0.02M 2.79M
Net income from continuing ops -13.57M -7.22M 2.52M 10.71M 10.77M
Net income applicable to common shares - - 2.52M 10.71M 10.77M
Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Total assets 151.94M 162.34M 134.15M 146.00M 120.28M
Other current assets 7.16M 8.49M 6.00M 1.80M 3.26M
Total liab 83.51M 79.75M 45.38M 57.48M 40.20M
Total stockholder equity 68.43M 82.59M 88.77M 88.52M 80.08M
Other current liab 7.25M 5.03M 5.03M 6.63M 0.81M
Common stock 0.09M 0.09M 0.09M 0.09M 0.09M
Capital stock 0.09M 0.09M 0.09M 0.09M 0.09M
Retained earnings 59.39M 72.97M 80.18M 77.66M 66.95M
Other liab - - 1.33M 2.68M 1.65M
Other assets - - 2.40M 2.98M 1.78M
Cash 12.32M 11.98M 13.60M 21.83M 32.13M
Total current liabilities 28.80M 23.46M 15.88M 23.26M 23.72M
Current deferred revenue 1.36M 0.30M 0.32M 0.14M 1.72M
Net debt 46.70M 48.31M 17.33M 10.01M -15.65M
Short term debt 4.43M 4.89M 2.76M 0.30M 9.29M
Short long term debt 2.21M 3.70M 0.31M 0.30M -
Short long term debt total 59.03M 60.29M 30.93M 31.84M 16.48M
Other stockholder equity 10.36M 9.56M 8.58M 9.07M 13.61M
Property plant equipment - - 74.21M 66.27M 38.15M
Total current assets 59.28M 61.61M 57.01M 76.75M 80.35M
Net tangible assets - - 88.77M 88.52M 80.08M
Net receivables 14.92M 16.89M 7.33M 17.49M 17.95M
Long term debt 8.63M 8.93M 9.21M 9.49M -
Inventory 24.87M 24.25M 29.69M 32.48M 27.01M
Accounts payable 15.35M 12.74M 7.78M 16.18M 11.89M
Accumulated other comprehensive income -1.42M -0.02M -0.08M 1.70M -0.56M
Common stock total equity - - - - 0.09M
Non currrent assets other 0.72M 4.91M 2.58M 2.98M 1.57M
Non current assets total 92.66M 100.73M 77.14M 69.26M 39.93M
Capital lease obligations 48.20M 47.66M 21.41M 22.05M 16.48M
Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Investments -3.61M -3.02M -13.47M -26.46M -5.04M
Change to liabilities - - -8.61M 3.06M 1.91M
Total cashflows from investing activities -3.61M -3.02M -13.47M -26.46M -5.04M
Net borrowings -1.80M 3.11M -0.28M 9.79M -10.00M
Total cash from financing activities -1.97M 2.89M -1.78M 4.29M -14.11M
Change to operating activities - - -7.06M -6.12M -0.25M
Net income -13.57M -7.22M 2.52M 10.71M 10.77M
Change in cash 0.34M -1.62M -8.23M -10.30M 1.66M
Begin period cash flow 11.98M 13.60M 21.83M 32.13M 30.48M
End period cash flow 12.32M 11.98M 13.60M 21.83M 32.13M
Total cash from operating activities 5.93M -1.50M 7.02M 11.87M 20.81M
Issuance of capital stock - - - - 0.04M
Depreciation 4.56M 4.65M 4.25M 4.17M 4.34M
Dividends paid - - - - 10.00M
Change to inventory -0.62M 5.45M 2.78M -5.47M 0.97M
Change to account receivables 2.25M -9.87M 11.82M 0.64M -0.81M
Sale purchase of stock -0.18M -0.22M -1.50M -5.50M -4.15M
Other cashflows from financing activities - -3.02M -13.47M 10.00M 10.00M
Change to netincome - - 1.48M 4.42M 4.62M
Capital expenditures 3.61M 3.02M 13.52M 26.49M 5.11M
Change in working capital 1.57M -3.35M -1.23M -7.43M 1.08M
Stock based compensation 0.98M 1.20M 1.01M 0.97M 1.43M
Other non cash items 8.78M 6.13M 1.44M 2.70M 3.40M
Free cash flow 2.32M -4.51M -6.50M -14.62M 15.70M

Peer Comparison*

Sector: Consumer Defensive Industry: Packaged Foods

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
NAII
Natural Alternatives International
0.02
1.69%
0.97 - 13.61 0.09 0.20 0.48 74.97
NSRGF
Nestle SA
0.32
0.32%
102.04 26.86 18.76 3.13 7.10 3.81 21.70
NSRGY
Nestle SA ADR
0.89
0.86%
104.47 26.82 18.66 3.18 7.07 3.81 21.70
DANOY
Danone PK
0.19
1.24%
15.46 24.23 17.64 1.88 2.57 1.88 11.70
GPDNF
Danone S.A
2.93
3.90%
78.15 20.30 14.75 1.65 2.24 1.76 10.92

Profile*

Natural Alternatives International

Natural Alternatives International, Inc. engages in formulating, manufacturing, and marketing nutritional supplements in the United States and internationally. It operates through two segments: Private-Label Contract Manufacturing, and Patent and Trademark Licensing. The company offers private-label contract manufacturing services to companies that market and distribute vitamins, minerals, herbal, and other nutritional supplements, as well as other health care products. It also provides strategic partnering services, such as customized product formulation, clinical study design and support, manufacturing, marketing support, international regulatory and label law compliance, international product registration, packaging in multiple formats and labeling design, scientific research, proprietary ingredients, customer-specific nutritional product formulation, product testing and evaluation, marketing management, packaging and delivery system design, regulatory review, and international product registration assistance. In addition, the company sells beta-alanine ingredient under the CarnoSyn, TriBsynm, and SR CarnoSyn names. The company manufactures products in various forms, including capsules, tablets, chewable wafers, and powders. Its private-label contract manufacturing customers include companies that market nutritional supplements through direct sales marketing channels, direct to consumer e-commerce channels, and retail stores. Natural Alternatives International, Inc. was founded in 1980 and is headquartered in Carlsbad, California.

1535 Faraday Avenue, Carlsbad, CA, United States, 92008

760 744 7700

293

Name Title Year Born
Mr. Mark A. LeDoux J.D. Chairman & CEO 1954
Mr. Kenneth E. Wolf Pres, COO & Sec. 1961
Mr. Michael E. Fortin Chief Financial Officer 1977
Mr. Eugene M. Quast VP of Global Sales 1959
Mr. Mark A. LeDoux J.D. Chairman of the Board & CEO 1954
Mr. Kenneth E. Wolf President, COO & Secretary 1961
Mr. Shane Conti Vice President of Global Sales NA
Mr. Kenneth E. Wolf CPA President, COO, Secretary, Principal Financial & Principal Accounting Officer 1961

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…